Crossref journal-article
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences (341)
Abstract

The tumor suppressor gene wild-type p53 encodes a labile protein that accumulates in cells after different stress signals and can cause either growth arrest or apoptosis. One of the p53 target genes, p53-inducible gene 3 ( PIG3 ), encodes a protein with significant homology to oxidoreductases, enzymes involved in cellular responses to oxidative stress and irradiation. This fact raised the possibility that cellular oxidation–reduction events controlled by such enzymes also may regulate the level of p53. Here we show that NADH quinone oxidoreductase 1 (NQO1) regulates p53 stability. The NQO1 inhibitor dicoumarol caused a reduction in the level of both endogenous and γ-irradiation-induced p53 in HCT116 human colon carcinoma cells. This reduction was prevented by the proteasome inhibitors MG132 and lactacystin, suggesting enhanced p53 degradation in the presence of dicoumarol. Dicoumarol-induced degradation of p53 also was prevented in the presence of simian virus 40 large T antigen, which is known to bind and to stabilize p53. Cells overexpressing NQO1 were resistant to dicoumarol, and this finding indicates the direct involvement of NQO1 in p53 stabilization. NQO1 inhibition induced p53 degradation and blocked wild-type p53-mediated apoptosis in γ-irradiated normal thymocytes and in M1 myeloid leukemic cells that overexpress wild-type p53 . Dicoumarol also reduced the level of p53 in its mutant form in M1 cells. The results indicate that NQO1 plays an important role in regulating p53 functions by inhibiting its degradation.

Bibliography

Asher, G., Lotem, J., Cohen, B., Sachs, L., & Shaul, Y. (2001). Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proceedings of the National Academy of Sciences, 98(3), 1188–1193.

Authors 5
  1. Gad Asher (first)
  2. Joseph Lotem (additional)
  3. Batya Cohen (additional)
  4. Leo Sachs (additional)
  5. Yosef Shaul (additional)
References 59 Referenced 224
  1. 10.1096/fasebj.6.13.1397838
  2. 10.1016/S0092-8674(00)81871-1
  3. 10.1038/352345a0
  4. 10.1182/blood.V82.4.1092.1092
  5. 10.1038/362847a0
  6. 10.1038/362849a0
  7. 10.1128/mcb.4.9.1689-1694.1984
  8. 10.1002/j.1460-2075.1991.tb04990.x
  9. E Reihsaus, M Kohler, S Kraiss, M Oren, M Montenarh Oncogene 5, 137–145 (1990). / Oncogene by Reihsaus E (1990)
  10. 10.1128/jvi.69.10.6115-6121.1995
  11. 10.1128/jvi.71.5.3788-3798.1997
  12. 10.1101/gad.9.17.2143
  13. 10.1038/387296a0
  14. 10.1038/387299a0
  15. 10.1038/38525
  16. 10.1016/S0006-2952(00)00321-X
  17. 10.1074/jbc.275.8.5416
  18. 10.1016/S0891-5849(00)00300-2
  19. 10.1038/bjc.1997.485
  20. A M Malkinson, D Siegel, G L Forrest, A F Gazdar, H K Oie, D C Chan, P A Bunn, M Mabry, D J Dykes, S D Harrison, et al. Cancer Res 52, 4752–4757 (1992). / Cancer Res by Malkinson A M (1992)
  21. 10.1007/BF00689804
  22. P Joseph, T Xie, Y Xu, A K Jaiswal Oncol Res 6, 525–532 (1994). / Oncol Res by Joseph P (1994)
  23. 10.1016/S0021-9258(19)42173-X
  24. 10.1016/0092-8674(90)90113-S
  25. 10.1006/bbrc.1998.9646
  26. 10.1111/j.1432-1033.1986.tb09449.x
  27. 10.1002/j.1460-2075.1995.tb00181.x
  28. 10.1073/pnas.93.17.9166
  29. 10.1006/bbrc.1996.0575
  30. 10.1016/0092-8674(81)90282-8
  31. 10.1073/pnas.95.8.4601
  32. C G Maki, J M Huibregtse, P M Howley Cancer Res 56, 2649–2654 (1996). / Cancer Res by Maki C G (1996)
  33. 10.1002/j.1460-2075.1993.tb05678.x
  34. 10.1101/gad.7.7a.1126
  35. 10.1126/science.281.5383.1674
  36. 10.1126/science.281.5383.1677
  37. 10.1126/science.287.5459.1824
  38. 10.1038/387520a0
  39. 10.1101/gad.12.18.2831
  40. 10.1096/fj.00-0171fje
  41. 10.1093/emboj/18.1.22
  42. 10.1038/sj.onc.1203593
  43. 10.1016/S0092-8674(00)00123-9
  44. 10.1038/21690
  45. 10.1038/21697
  46. 10.1038/21704
  47. 10.1038/sj.onc.1202727
  48. Chang N. S. Pratt N. Heath J. Schultz L. Sleve D. Carey G. B. & Zevotek N. (2000) J. Biol. Chem . in press.
  49. 10.1101/gad.10.9.1054
  50. 10.1074/jbc.274.17.12061
  51. 10.1023/A:1006962716377
  52. 10.1023/A:1006960126369
  53. C M Whitacre, H Hashimoto, M L Tsai, S Chatterjee, S J Berger, N A Berger Cancer Res 55, 3697–3701 (1995). / Cancer Res by Whitacre C M (1995)
  54. 10.1038/35001622
  55. 10.1126/science.289.5487.2126
  56. 10.1016/S0092-8674(00)81671-2
  57. J Lotem, L Sachs Cell Growth Differ 4, 41–47 (1993). / Cell Growth Differ by Lotem J (1993)
  58. 10.1073/pnas.92.21.9672
  59. 10.1038/sj.onc.1202314
Dates
Type When
Created 13 years, 1 month ago (July 26, 2012, 7:06 p.m.)
Deposited 3 years, 4 months ago (April 13, 2022, 5:29 p.m.)
Indexed 1 month, 3 weeks ago (July 1, 2025, 12:23 a.m.)
Issued 24 years, 7 months ago (Jan. 23, 2001)
Published 24 years, 7 months ago (Jan. 23, 2001)
Published Online 24 years, 7 months ago (Jan. 23, 2001)
Published Print 24 years, 6 months ago (Jan. 30, 2001)
Funders 0

None

@article{Asher_2001, title={Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1}, volume={98}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.98.3.1188}, DOI={10.1073/pnas.98.3.1188}, number={3}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Asher, Gad and Lotem, Joseph and Cohen, Batya and Sachs, Leo and Shaul, Yosef}, year={2001}, month=jan, pages={1188–1193} }